© 1990 by Oxford University Press
Journal of the National Cancer Institute, Vol. 82, No. 12, 1050-1054,
June 20, 1990
© 1990 Oxford University Press
Enhanced Chromatid Damage in Blood Lymphocytes After G2 Phase X Irradiation, a Marker of the Ataxia-Telangiectasia Gene
Laboratory of Cellular and Molecular Biology National Cancer Institute Bethesda, MD
Biostatistics Branch National Cancer Institute Bethesda, MD
Metabolism Branch National Cancer Institute Bethesda, MD
Department of Pathology, Howard University College of Medicine Washington, DC
Department of Pediatrics, Robert Wood Johnson Medical School New Brunswick, NJ
*Correspondence to: Katherine K. Sanford, Ph.D., Bldg. 37, Rm. 2D15, National Institutes of Health, Bethesda, MD 20892
An assay for ataxia-telangiectasia (A-T) heterozygotes, i.e., healthy carriers of the A-T gene(s), requiring only a small sample (3.5 mL) of peripheral blood, is described. Frequencies of chromatid aberrations in phytohemagglutinin-stimulated blood lymphocytes collected by demecolcine from 0.5 hour to 1.5 hours after x irradiation with 58 roentgens were twofold to threefold higher in A-T heterozygotes than in clinically normal controls and twofold to threefold higher in A-T patients (homozygotes) than in A-T gene carriers. The persistence of chromatid breaks and gaps in lymphocytes following radiation-induced DNA damage during G2 suggests a deficiency or deficiencies in DNA repair that may be the defect at the molecular level that results in the enhanced radiosensitivity and cancer proneness characterizing A-T gene carriers and patients. [J Natl Cancer Inst 82:1050–1054, 1990]
Manuscript received March 7, 1990; revised April 2, 1990; accepted April 6, 1990.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
W. K. Kaufmann, L. Filatov, S. E. Oglesbee, D. A. Simpson, M. A. Lotano, H. D. McKeen, L. R. Sawyer, D. T. Moore, R. C. Millikan, M. Cordeiro-Stone, et al. Radiation clastogenesis and cell cycle checkpoint function as functional markers of breast cancer risk Carcinogenesis, December 1, 2006; 27(12): 2519 - 2527. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-L. Zheng, C. A. Loffredo, A. J. Alberg, Z. Yu, R. T. Jones, D. Perlmutter, L. Enewold, M. J. Krasna, R. Yung, P. G. Shields, et al. Less Efficient G2-M Checkpoint Is Associated with an Increased Risk of Lung Cancer in African Americans Cancer Res., October 15, 2005; 65(20): 9566 - 9573. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Smilenov, D. J. Brenner, and E. J. Hall Modest Increased Sensitivity to Radiation Oncogenesis in ATM Heterozygous versus Wild-Type Mammalian Cells Cancer Res., August 1, 2001; 61(15): 5710 - 5713. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Pretazzoli, B. Salone, A. Bosi, and G. Olivieri Variability of G2 checkpoint sensitivity to low doses of X-rays (2 cGy): correlation with G2 chromatid aberrations but not with an adaptive response Mutagenesis, November 1, 2000; 15(6): 531 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Lunn, K. J. Helzlsouer, R. Parshad, D. M. Umbach, E. L. Harris, K. K. Sanford, and D. A. Bell XPD polymorphisms: effects on DNA repair proficiency Carcinogenesis, April 1, 2000; 21(4): 551 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zhang, P. Chen, K. K. Khanna, S. Scott, M. Gatei, S. Kozlov, D. Watters, K. Spring, T. Yen, and M. F. Lavin Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype PNAS, July 22, 1997; 94(15): 8021 - 8026. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hartwell and M. Kastan Cell cycle control and cancer Science, December 16, 1994; 266(5192): 1821 - 1828. [Abstract] [PDF] |
||||




